Business

Wipro appoints Amit Kumar as Managing Partner and Globa...

Shares of Wipro Ltd ended at ₹308.10, down by ₹0.40, or 0.13% on the BSE.

Future Female Forward | Diverse workforce is a cornerst...

At Novartis India, the focus on gender equality and the promotion of women in le...

India poised to become Canva’s largest global market, s...

Canva, a leading graphic design tool, has gained immense popularity among Indian...

Utkarsh Small Finance Bank reports ₹168 crore Q3 loss a...

Shares of Utkarsh Small Finance Bank Ltd ended at ₹28.15, down by ₹1.39, or 4.71...

Top Stories | India-US to boost trade ties, Sensex's lo...

Top 10@10 — CNBC-TV18’s daily newsletter featuring the top 10 stories on markets...

After 'Campa' and 'SIL', Reliance Consumer Products acq...

The acquisition sees RCPL take ownership of the Velvette brand from Chennai-base...

RVNL reports subdued Q3; net profit falls 13%, revenue ...

EBITDA was down 3.9% YoY to ₹239.4 crore in Q3FY25 over ₹249 crore. Shares of Ra...

Narayana Hrudayalaya Q3 Results | Net profit up 3%, rev...

The EBITDA margin stood at 22.5%, less than 100 bps below 23.2% in the third qua...

Alembic Pharma's Vadodara unit passes FDA test with VAI...

Voluntary action indicated (VAI) is suggested when violations are found, but the...

Glenmark Pharma stages smart recovery in Q3 with ₹348-c...

EBITDA zoomed to ₹600.3 crore in the third quarter over a loss of ₹208.7 crore i...

A Journey of resilience: Arundhati Bhattacharya's path ...

Arundhati Bhattacharya's first encounter with SBI was serendipitous. At the age ...

Dish TV India Q3 Results | Net loss widens to ₹47 crore...

The EBITDA margin stood at 32.9% in the reporting quarter compared to 38.6% in t...

Trump’s reciprocal tariff announcement is a tactical mo...

Prime Minister Modi's US visit focused on enhancing trade, energy imports, and d...

RBI imposes ₹5.8-lakh penalty on Shriram Finance for KY...

RBI clarified that the penalty was imposed due to regulatory deficiencies and di...

Zydus Lifesciences’ Maharashtra unit clears US FDA insp...

Zydus Lifesciences' US formulation sales for the third quarter stood at $285 mil...

Easy Trip Q3 Results | Net profit, margin decline despi...

EBITDA slid 21.8% YoY to ₹47.7 crore in Q3FY25 from ₹61 crore, while the EBITDA ...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.